Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 4101 - 4125 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Gangliosides LMSP0601EC02
  • KDN(2-6)lactotetraosylceramide(d18:1/18:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262765 1504.850113 C71H128N2O31
Gangliosides LMSP0601GE02
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44263165 1504.850113 C71H128N2O31
Gangliosides LMSP0601GG02
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/18:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44263181 1504.850113 C71H128N2O31
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE05
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • SSEA-3 antigen(d18:1/24:0)
 44260200 1500.927968 C74H136N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP05
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260288 1500.927968 C74H136N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA05
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260376 1500.927968 C74H136N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK05
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260456 1500.927968 C74H136N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260560 1500.927968 C74H136N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AQ05
  • Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260744 1500.927968 C74H136N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU05
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260968 1500.927968 C74H136N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC05
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260992 1500.927968 C74H136N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ05
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • galgactosyl-paraglobside(d18:1/24:0)
 44261256 1500.927968 C74H136N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK05
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261264 1500.927968 C74H136N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AN05
  • Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261920 1500.927968 C74H136N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS05
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • iGb5(d18:1/24:0)
 44261584 1500.927968 C74H136N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU05
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261600 1500.927968 C74H136N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BE05
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261664 1500.927968 C74H136N2O28
Diacylglycerophosphoinositolglycans LMGP15010156
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(17:0/18:0)
 126457524 1500.784083 C68H125O33P
Diacylglycerophosphoinositolglycans LMGP15010177
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:0/16:0)
 126457545 1500.784083 C68H125O33P
Gangliosides LMSP0601AK03
  • GD3(d18:1/20:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44262046 1499.871182 C72H129N3O29
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE07
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • SSEA-3 antigen(d18:1/24:1(15Z))
 44260202 1498.912318 C74H134N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP07
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44260290 1498.912318 C74H134N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA07
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44260378 1498.912318 C74H134N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK07
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44260458 1498.912318 C74H134N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ07
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44260562 1498.912318 C74H134N2O28
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024